Cytogam Administration in Abdominal Organ Transplant Recipients at High Risk for Cytomegalovirus Infection

NCT01509404 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Cytomegalovirus Disease

Interventions

DRUG: Valganciclovir
BIOLOGICAL: CMV hyperimmune globulin
DRUG: Valganciclovir

Sponsor

Medical University of South Carolina

Collaborators

[object Object]